Tag: RenovoRx / Imugene
RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using...
RenovoRx, Inc. ("RenovoRx") (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing targeted combination therapies, andImugene Ltd ("Imugene") (ASX: IMU), a clinical-stage immuno-oncology company, today announced...
